Lv3
234 积分 2025-12-02 加入
Osimertinib plus selumetinib in patients with EGFR-mutated advanced NSCLC with BRAF alterations post-progression on first-line osimertinib: ORCHARD
11天前
已完结
Efficacy and safety of once-weekly semaglutide 2·4 mg in Chinese adults with overweight or obesity (STEP 12): a randomised, double-blind, placebo-controlled, multicentre, phase 3b trial
12天前
已关闭
Blood-Based Biomarkers for Alzheimer Disease Preventing Unintended Consequences
20天前
已完结
Orforglipron Added to Titrated Insulin Glargine in Type 2 Diabetes: The ACHIEVE-5 Randomized Clinical Trial
1个月前
已完结
Long-term administration of liraglutide for weight management in pediatric patients under 18 years: evidence from 7 randomized controlled trials
1个月前
已完结
Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective
1个月前
已完结
Medications for Obesity
1个月前
已完结
National Prevalence, Regional Distribution, and Risk Factors for CKD in Taiwan
2个月前
已完结
A phase 3, randomized trial to evaluate lot-to-lot consistency of V116, an adult-specific pneumococcal conjugate vaccine (STRIDE-4)
3个月前
已完结
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
3个月前
已完结
皖公网安备34019202002308
